News from
PRINCETON UNIVERSITY
Office of Communications
Stanhope Hall, Princeton, New Jersey 08544-5264
Telephone 609-258-3601; Fax 609-258-1301Contact: Patricia Coen (609) 258-5764
Date: December 2, 1999
Bristol-Myers Squibb Vice Chair to Speak on Help for HIV/AIDS Patients in Southern Africa
Princeton, N.J. -- Kenneth E. Weg, vice-chairman of the Bristol-Myers Squibb Company, will give a talk titled "'Secure the Future': Building Public-Private Sector Partnerships for HIV/AIDS in Developing Countries" at Princeton University's Woodrow Wilson School of Public and International Affairs on Thursday, December 9, at 4:30 p.m. in Robertson Hall, Bowl 5. Weg is the architect of the Bristol-Myers Squibb-sponsored "Secure the Future" program, a $100 million public and private sector partnership that provides care and support for women and children with HIV/AIDS in southern Africa.
Weg, whose career in the pharmaceutical industry spans more than 30 years, was president of Bristol-Meyers Squibb's Worldwide Medicines Group before assuming his current post. First appointed to lead the worldwide pharmaceuticals business in 1989, he expanded the company's pharmaceutical presence and oversaw the development of such now-popular products as Glucophage, TAXOL, VIDEX, and Serzone.
Weg has been active in numerous philanthropic, civic, and pharmaceutical industry organizations throughout his career. He is a trustee of the Princeton Medical Center, the Fox Chase Cancer Center, and the University of Medicine and Dentistry in New Jersey. He also serves on the Foundation for New Jersey Public Broadcasting, is a member of the Philadelphia Museum of Art Corporate Executive Committee, and served as co-chair of Governor Christie Whitman's "Save the Dome" campaign, which raised private-sector funds to restore the gold dome atop the New Jersey State House.
His talk is being sponsored by the Woodrow Wilson School and the Center for Health Care Strategies, with funding from the Robert Wood Johnson Foundation.